P-951 At Databricks, we are passionate about enabling data teams to solve the worlds toughest problems — from making the next mode of transportation a reality to accelerating the development of medical breakthroughs. We do this
Minimum qualifications: Bachelor’s degree or equivalent practical experience. 2 years of experience programming in the Swift or Objective-C programming language. 1 year of experience in Android development. 2 years of experience with iOS application development. Preferred
Build the Future of Cloud at Oracle Cloud Infrastructure (OCI) At Oracle Cloud Infrastructure (OCI), we enable mission-critical applications for the world’s top enterprises, delivering hyper-scale, secure, multi-tenant cloud services across 50+ global regions. As leaders
The AWS Neurosymbolic AI team is pioneering the integration of formal reasoning and neural approaches to build AI systems that are not only capable, but provably correct. We sit at one of the most compelling frontiers
About Us Endor Labs is building the Application Security platform for the software development revolution. Modern software is complex and dependency-rich, making it increasingly difficult to pinpoint the risks that truly matter. Endor Labs solves this
RDQ427R275 Location: San Francisco or Seattle At Databricks, we are passionate about enabling data teams to solve the world’s toughest problems — from making the next mode of transportation a reality to accelerating the development of
RDQ427R276 Location: San Francisco or Seattle At Databricks, we are passionate about enabling data teams to solve the worlds toughest problems — from making the next mode of transportation a reality to accelerating the development of
AWS Neurosymbolic AI Team The AWS Neurosymbolic AI team is pioneering the integration of formal reasoning and neural approaches to build AI systems that are not only capable, but provably correct. We sit at one of
About the Company: Celltrion USA is Celltrion’s U.S. subsidiary established in 2018. Headquartered in New Jersey, Celltrion USA is committed to expanding access to biologics to improve care for U.S. patients. Celltrion USA will continue to